BACKGROUND
Incidences of side effects and relapses are very common in chronic ulcerative colitis patients after termination of the treatment.
OBJECTIVE
This study aims to compare the treatment with monoherbal formulation of Holarrhena antidysenterica with Mesalamine in chronic ulcerative colitis